🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 9 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/05/2026 | 221,59 | 226,28 | 218,97 | 221,21 | -0,36% | 3,30% | 218.600 |
| 12/05/2026 | 220,78 | 224,54 | 217,07 | 222,00 | +0,69% | 3,38% | 163.000 |
| 11/05/2026 | 221,41 | 225,82 | 218,00 | 220,48 | -0,42% | 3,53% | 204.200 |
| 08/05/2026 | 212,20 | 223,79 | 206,02 | 221,41 | +5,27% | 8,37% | 250.000 |
| 07/05/2026 | 205,00 | 225,64 | 200,01 | 210,33 | -9,55% | 12,50% | 644.000 |
| 06/05/2026 | 235,09 | 236,32 | 229,43 | 232,55 | +0,11% | 2,93% | 185.400 |
| 05/05/2026 | 228,36 | 233,06 | 228,36 | 232,30 | +1,73% | 2,06% | 105.700 |
| 04/05/2026 | 226,47 | 233,98 | 226,20 | 228,36 | +0,40% | 3,44% | 221.200 |
| 01/05/2026 | 229,87 | 236,22 | 226,47 | 227,44 | -0,88% | 4,24% | 235.400 |
| 30/04/2026 | 224,86 | 230,03 | 220,06 | 229,45 | +2,04% | 4,43% | 265.500 |
| 29/04/2026 | 229,79 | 232,70 | 223,76 | 224,86 | -3,21% | 3,89% | 252.200 |
| 28/04/2026 | 243,66 | 244,14 | 228,69 | 232,32 | -3,92% | 6,34% | 168.300 |
| 27/04/2026 | 240,41 | 247,38 | 230,83 | 241,79 | +4,55% | 6,88% | 281.000 |
| 24/04/2026 | 227,39 | 231,75 | 225,00 | 231,27 | +1,22% | 2,97% | 171.400 |
| 23/04/2026 | 228,99 | 231,01 | 226,22 | 228,48 | +0,71% | 2,09% | 172.400 |
| 22/04/2026 | 228,04 | 228,91 | 225,00 | 226,87 | +0,09% | 1,71% | 113.900 |
| 21/04/2026 | 231,50 | 234,09 | 223,46 | 226,67 | -2,20% | 4,59% | 127.700 |
| 20/04/2026 | 231,82 | 238,31 | 224,26 | 231,78 | -0,02% | 6,06% | 112.700 |
| 17/04/2026 | 226,00 | 234,31 | 225,09 | 231,82 | +3,84% | 4,08% | 169.000 |
| 16/04/2026 | 221,79 | 226,01 | 218,19 | 223,24 | -0,82% | 3,53% | 192.200 |
| 15/04/2026 | 230,43 | 230,43 | 221,77 | 225,09 | -3,12% | 3,76% | 306.500 |
| 14/04/2026 | 220,00 | 234,76 | 219,98 | 232,34 | +8,85% | 6,72% | 570.600 |
| 13/04/2026 | 204,26 | 213,52 | 198,56 | 213,44 | +4,16% | 7,32% | 168.800 |
| 10/04/2026 | 205,90 | 206,16 | 198,55 | 204,92 | -0,35% | 3,70% | 277.300 |
| 09/04/2026 | 206,68 | 209,88 | 203,20 | 205,64 | -1,18% | 3,23% | 258.100 |
| 08/04/2026 | 207,08 | 210,31 | 204,89 | 208,09 | +1,46% | 2,62% | 233.300 |
| 07/04/2026 | 203,09 | 205,84 | 200,24 | 205,10 | +0,73% | 2,76% | 164.600 |
| 06/04/2026 | 199,52 | 205,81 | 199,52 | 203,61 | +2,01% | 3,15% | 234.900 |
| 02/04/2026 | 197,54 | 201,42 | 194,67 | 199,59 | -0,02% | 3,42% | 221.900 |
| 01/04/2026 | 203,50 | 205,50 | 198,01 | 199,62 | -0,02% | 3,68% | 262.000 |